Several lines of evidence support the notion that, in AD, Aβ deposition and Tau phosphorylation negatively affect energy metabolism and the redox status of cells, leading to mitochondrial and synaptic dysfunctions [132,133]. This evidence concerns the gene MAPT and Alzheimer disease.